274 related articles for article (PubMed ID: 33798232)
1. Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).
Raza MT; Mizan S; Yasmin F; Akash AS; Shahik SM
PLoS One; 2021; 16(4):e0248001. PubMed ID: 33798232
[TBL] [Abstract][Full Text] [Related]
2. Chimeric peptide vaccine composed of B- and T-cell epitopes of human T-cell leukemia virus type 1 induces humoral and cellular immune responses and reduces the proviral load in immunized squirrel monkeys (Saimiri sciureus).
Kazanji M; Heraud JM; Merien F; Pique C; de Thé G; Gessain A; Jacobson S
J Gen Virol; 2006 May; 87(Pt 5):1331-1337. PubMed ID: 16603536
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human T-lymphotropic virus-1 infection.
Pandey RK; Ojha R; Chatterjee N; Upadhyay N; Mishra A; Prajapati VK
J Cell Physiol; 2019 Jun; 234(6):8717-8726. PubMed ID: 30370533
[TBL] [Abstract][Full Text] [Related]
4. Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.
Best I; López G; Talledo M; MacNamara A; Verdonck K; González E; Tipismana M; Asquith B; Gotuzzo E; Vanham G; Clark D
AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1207-12. PubMed ID: 21453202
[TBL] [Abstract][Full Text] [Related]
5. Predicting and Designing Epitope Ensemble Vaccines against HTLV-1.
Alam S; Hasan MK; Manjur OHB; Khan AM; Sharmin Z; Pavel MA; Hossain MF
J Integr Bioinform; 2020 Jan; 16(4):. PubMed ID: 31913852
[TBL] [Abstract][Full Text] [Related]
6. In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytes.
Kobayashi H; Ngato T; Sato K; Aoki N; Kimura S; Tanaka Y; Aizawa H; Tateno M; Celis E
Clin Cancer Res; 2006 Jun; 12(12):3814-22. PubMed ID: 16778109
[TBL] [Abstract][Full Text] [Related]
7.
Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
[TBL] [Abstract][Full Text] [Related]
8. Among all human T-cell leukemia virus type 1 proteins, tax, polymerase, and envelope proteins are predicted as preferential targets for the HLA-A2-restricted cytotoxic T-cell response.
Pique C; Connan F; Levilain JP; Choppin J; Dokhélar MC
J Virol; 1996 Aug; 70(8):4919-26. PubMed ID: 8763995
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
10. Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus.
Sundaram R; Lynch MP; Rawale S; Dakappagari N; Young D; Walker CM; Lemonnier F; Jacobson S; Kaumaya PT
J Acquir Immune Defic Syndr; 2004 Nov; 37(3):1329-39. PubMed ID: 15483462
[TBL] [Abstract][Full Text] [Related]
11. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells.
Kannagi M; Shida H; Igarashi H; Kuruma K; Murai H; Aono Y; Maruyama I; Osame M; Hattori T; Inoko H
J Virol; 1992 May; 66(5):2928-33. PubMed ID: 1373197
[TBL] [Abstract][Full Text] [Related]
12. Activation and detection of HTLV-I Tax-specific CTLs by epitope expressing single-chain trimers of MHC class I in a rat model.
Ohashi T; Nagai M; Okada H; Takayanagi R; Shida H
Retrovirology; 2008 Oct; 5():90. PubMed ID: 18840303
[TBL] [Abstract][Full Text] [Related]
13. In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.
Sagar D; Masih S; Schell T; Jacobson S; Comber JD; Philip R; Wigdahl B; Jain P; Khan ZK
Vaccine; 2014 May; 32(26):3274-84. PubMed ID: 24739247
[TBL] [Abstract][Full Text] [Related]
14. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
Anwar S; Mourosi JT; Khan MF; Hosen MJ
Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
[TBL] [Abstract][Full Text] [Related]
17. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
Hadlock KG; Rowe J; Foung SK
J Virol; 1999 Feb; 73(2):1205-12. PubMed ID: 9882322
[TBL] [Abstract][Full Text] [Related]
18. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
19. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
[TBL] [Abstract][Full Text] [Related]
20. An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines.
Lucchese G; Jahantigh HR; De Benedictis L; Lovreglio P; Stufano A
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
